Mohammed Abba
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- RNA Interference and Gene Delivery 3
- Wnt/β-catenin signaling in development and cancer 2
-
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 9
- Co-authors
- Heike Allgayer (28 shared papers)Nitin Patil (16 shared papers)Jörg H. Leupold (11 shared papers)Marcin Moniuszko (3 shared papers)Jacek Nikliński (2 shared papers)Sherien M. El‐Daly (2 shared papers)Giridhar Mudduluru (5 shared papers)Jochen Utikal (3 shared papers)
- Journals
- Cancer Research (4 papers)Cancer Letters (2 papers)Cancers (2 papers)International Journal of Cancer (2 papers)Oncotarget (2 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Mohammed Abba
34 papers receiving 781 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 450
- Molecular Biology 545
- Oncology 165
- Structural Biology 6
- Immunology and Allergy 21
Countries citing papers authored by Mohammed Abba
This map shows the geographic impact of Mohammed Abba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Abba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Abba more than expected).
Fields of papers citing papers by Mohammed Abba
This network shows the impact of papers produced by Mohammed Abba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Abba. The network helps show where Mohammed Abba may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammed Abba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 91 | |
| 2 | 2016 | 88 | |
| 3 | 2017 | 75 | |
| 4 | 2015 | 61 | |
| 5 | 2014 | 54 | |
| 6 | 2015 | 50 | |
| 7 | 2016 | 44 | |
| 8 | 2018 | 34 | |
| 9 | 2013 | 30 | |
| 10 | 2012 | 27 | |
| 11 | Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis. | 2018 | 27 |
| 12 | 2017 | 26 | |
| 13 | 2015 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2014 | 19 | |
| 16 | 2015 | 18 | |
| 17 | 2016 | 16 | |
| 18 | Look who's talking: deregulated signaling in colorectal cancer. | 2012 | 12 |
| 19 | 2013 | 12 | |
| 20 | 2017 | 12 |
About Mohammed Abba
Mohammed Abba is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 791 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), RNA Interference and Gene Delivery (3 papers), Nanoplatforms for cancer theranostics (2 papers), Cardiac Arrhythmias and Treatments (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cancer Research (450 citations), Molecular Biology (545 citations), Oncology (165 citations), Structural Biology (6 citations) and Immunology and Allergy (21 citations). Mohammed Abba has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Heike Allgayer, Nitin Patil, Jörg H. Leupold, Marcin Moniuszko, Jacek Nikliński, Sherien M. El‐Daly, Giridhar Mudduluru, Jochen Utikal, Axel Benner and Timo Gaiser. Their work appears in journals such as Cancer Research, Cancer Letters, Cancers, International Journal of Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.